Search research articles
Contact Us
Filters
Showing results (181-190 of 223) with videos related to
Page
of 23
Sort By:
Advanced Healthcare Materials
|
May 3, 2024
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer
Niranjan Meher, Gary W Ashley, Kondapa Naidu Bobba, et al.
NPJ Precision Oncology
|
August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors
Aaron S Mansfield, David S Hong, Christine L Hann, et al.
Nature Communications
|
January 3, 2024
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
Mark C Markowski, Mary-Ellen Taplin, Rahul Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2024
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
Rahul Aggarwal, Glenn Heller, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates
Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Urologic Oncology
|
December 17, 2022
Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention
Crystal S Langlais, Yea-Hung Chen, Erin L Van Blarigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy
Anil P Bidkar, Robin Peter, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
Anil P Bidkar, Sinan Wang, Kondapa Naidu Bobba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Ning Zhao, Shalini Chopra, Kai Trepka, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 223) with videos related to
Sort By:
Page
of 23
Advanced Healthcare Materials
|
May 3, 2024
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer
Niranjan Meher, Gary W Ashley, Kondapa Naidu Bobba, et al.
NPJ Precision Oncology
|
August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors
Aaron S Mansfield, David S Hong, Christine L Hann, et al.
Nature Communications
|
January 3, 2024
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
Mark C Markowski, Mary-Ellen Taplin, Rahul Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2024
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
Rahul Aggarwal, Glenn Heller, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates
Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Urologic Oncology
|
December 17, 2022
Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention
Crystal S Langlais, Yea-Hung Chen, Erin L Van Blarigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy
Anil P Bidkar, Robin Peter, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
Anil P Bidkar, Sinan Wang, Kondapa Naidu Bobba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Ning Zhao, Shalini Chopra, Kai Trepka, et al.
Page
of 23